HRP20090477A2 - SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA - Google Patents

SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA Download PDF

Info

Publication number
HRP20090477A2
HRP20090477A2 HR20090477A HRP20090477A HRP20090477A2 HR P20090477 A2 HRP20090477 A2 HR P20090477A2 HR 20090477 A HR20090477 A HR 20090477A HR P20090477 A HRP20090477 A HR P20090477A HR P20090477 A2 HRP20090477 A2 HR P20090477A2
Authority
HR
Croatia
Prior art keywords
fumarate
compound
salt
drug
fumarate salt
Prior art date
Application number
HR20090477A
Other languages
English (en)
Croatian (hr)
Inventor
Neggiani Fabio
Dini Laura
Original Assignee
Abiogen Pharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma S.P.A. filed Critical Abiogen Pharma S.P.A.
Publication of HRP20090477A2 publication Critical patent/HRP20090477A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20090477A 2006-11-02 2007-10-31 SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA HRP20090477A2 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002102A ITMI20062102A1 (it) 2006-11-02 2006-11-02 Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one
PCT/IB2007/003291 WO2008053325A1 (en) 2006-11-02 2007-10-31 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Publications (1)

Publication Number Publication Date
HRP20090477A2 true HRP20090477A2 (hr) 2009-11-30

Family

ID=39145485

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20090477A HRP20090477A2 (hr) 2006-11-02 2007-10-31 SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA
HR20090470A HRP20090470A2 (hr) 2006-11-02 2007-10-31 Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20090470A HRP20090470A2 (hr) 2006-11-02 2007-10-31 Sol 3-benzil-2-methil-2.3.3.a.4.5.6.7,7a-octahidrobenzo[d]isoksazol-4-ona

Country Status (20)

Country Link
US (2) US20100069450A1 (enExample)
EP (2) EP2094674B1 (enExample)
JP (2) JP2010509309A (enExample)
KR (2) KR20090082452A (enExample)
CN (2) CN101535281A (enExample)
AT (2) ATE502021T1 (enExample)
AU (2) AU2007315832A1 (enExample)
BR (2) BRPI0718392A2 (enExample)
CA (2) CA2667515A1 (enExample)
DE (2) DE602007013278D1 (enExample)
HR (2) HRP20090477A2 (enExample)
IL (2) IL198443A0 (enExample)
IT (1) ITMI20062102A1 (enExample)
MX (2) MX2009004294A (enExample)
NO (2) NO20092115L (enExample)
NZ (2) NZ577978A (enExample)
RS (2) RS20090389A (enExample)
RU (2) RU2009120724A (enExample)
WO (2) WO2008053326A1 (enExample)
ZA (2) ZA200903618B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112142A1 (en) * 2008-04-24 2009-10-28 Abiogen Pharma S.p.A. Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
WO2011010332A1 (en) * 2009-07-23 2011-01-27 Abiogen Pharma S.P.A. Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
US10131642B1 (en) * 2015-01-30 2018-11-20 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt
US4419358A (en) * 1981-11-12 1983-12-06 Mead Johnson & Company Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives

Also Published As

Publication number Publication date
CN101535281A (zh) 2009-09-16
EP2094675A1 (en) 2009-09-02
RU2009120724A (ru) 2010-12-10
WO2008053325A1 (en) 2008-05-08
DE602007013801D1 (de) 2011-05-19
CA2667513A1 (en) 2008-05-08
JP2010509309A (ja) 2010-03-25
ZA200903618B (en) 2010-07-28
DE602007013278D1 (de) 2011-04-28
EP2094675B1 (en) 2011-04-06
NZ577978A (en) 2010-10-29
CA2667515A1 (en) 2008-05-08
ATE504578T1 (de) 2011-04-15
AU2007315832A1 (en) 2008-05-08
BRPI0718391A2 (pt) 2013-11-26
AU2007315833A1 (en) 2008-05-08
US20100069450A1 (en) 2010-03-18
US20100069451A1 (en) 2010-03-18
MX2009004294A (es) 2009-05-08
RS20090388A (sr) 2010-12-31
ITMI20062102A1 (it) 2008-05-03
KR20090077014A (ko) 2009-07-13
HRP20090470A2 (hr) 2009-11-30
JP2010509310A (ja) 2010-03-25
RS20090389A (sr) 2010-12-31
IL198444A0 (en) 2010-02-17
WO2008053326A1 (en) 2008-05-08
EP2094674B1 (en) 2011-03-16
NO20092114L (no) 2009-05-29
NO20092115L (no) 2009-05-29
IL198443A0 (en) 2010-02-17
RU2009120667A (ru) 2010-12-10
EP2094674A1 (en) 2009-09-02
CN101535282A (zh) 2009-09-16
ATE502021T1 (de) 2011-04-15
BRPI0718392A2 (pt) 2013-11-26
ZA200903810B (en) 2010-07-28
NZ577311A (en) 2010-10-29
MX2009004293A (es) 2009-05-08
KR20090082452A (ko) 2009-07-30

Similar Documents

Publication Publication Date Title
EP0165919B1 (fr) (R)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
CH644348A5 (fr) Amino-ethers oxydes, leur procede de preparation et medicament les contenant.
EP0446141B1 (fr) Nouveaux dérivés d'imidazo [1,2-C] quinazoline leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP1289988A1 (fr) Derives de 1,4-diazabicyclo(3.2.2)nonanebenzoxazole, -benzothiazole et benzimidazole, leur preparation et leur application therapeutique
HRP20090477A2 (hr) SOL 3-BENZIL-2-METIL-2,3,3A,4,5,6,7,7A-OKTAHIDROBENZO[d]IZOKSAZOL-4-ONA
FR2776660A1 (fr) Diazepino-indoles de phosphodiesterases iv
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
EP1451197A1 (fr) Derives de 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo 3.2.2 nonane, leur preparation et leur application en therapeutique
DE1795022C3 (de) Lysergsäurederivate
EP0343050A1 (fr) Dérivés de phényl-6 pipérazinyl-alkyl-3 1H,3H-pyrimidinedione-2,4, leur préparation et leur application en thérapeutique
CA2271072A1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique
EP0082040B1 (fr) Dérivés de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique
NL8603236A (nl) Optisch actieve 2-chloor-12-(3-dimethylamino-2-methyl-propyl)-12h-dibenzod,g1,3,6dioxazocinen en een werkwijze voor de bereiding ervan.
FR2566775A1 (fr) Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique
FR2480602A1 (fr) Hexahydro-pyrimido(1,2-a)azepines 3-substituees a titre de medicaments
MC1576A1 (fr) Derives d'imidazole
KR20200023236A (ko) 벤조산 유도체 및 이를 유효성분으로 함유하는 자가면역질환 예방 또는 치료용 조성물
EP0311467A2 (fr) Utilisation de dérivés de pyrrolo[3,2,1-hi]indole pour obtenir un médicament destiné au traitement du diabète
FR2756283A1 (fr) Amines aromatiques d'arylpiperazines, leur preparation et leurs applications comme medicaments

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20101026

Year of fee payment: 4

OBST Application withdrawn